Company profile for ResolutionRx

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

ResolutionRx Ltd is an Australian biopharmaceutical company dedicated to the research, development, and commercialization of pharmaceutical cannabinoids. Established on January 11, 2023, as a subsidiary of RespireRx Pharmaceuticals Inc., ResolutionRx holds exclusive rights to RespireRx’s cannabinoid drug development program. Focused on advancing therapies targeting the endocannabinoid system, the company leverages patented a...
ResolutionRx Ltd is an Australian biopharmaceutical company dedicated to the research, development, and commercialization of pharmaceutical cannabinoids. Established on January 11, 2023, as a subsidiary of RespireRx Pharmaceuticals Inc., ResolutionRx holds exclusive rights to RespireRx’s cannabinoid drug development program. Focused on advancing therapies targeting the endocannabinoid system, the company leverages patented and proprietary innovations to develop breakthrough treatments. ResolutionRx is committed to driving innovation in cannabinoid-based medicine.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Australia
Address
Address
Level 6, 56 Pitt Street, Sydney NSW 2000
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com//news-release/2023/10/12/2759269/0/en/RespireRx-Pharmaceuticals-Inc-s-Subsidiary-ResolutionRx-Ltd-Enters-into-Master-Services-Agreement-for-Dronabinol-Manufacturing-and-Related-Services.html

GLOBENEWSWIRE
12 Oct 2023

https://www.globenewswire.com/news-release/2023/08/09/2721676/0/en/RespireRx-Pharmaceuticals-Inc-and-ResolutionRx-Ltd-Enter-into-Bilateral-Agreements-to-Establish-ResolutionRx-Ltd-as-an-Operating-Company.html

GLOBENEWSWIRE
09 Aug 2023
ResolutionRx Enters into Letter of Intent
ResolutionRx Enters into Letter of Intent

24 May 2023

// GLOBENEWSWIRE

https://www.globenewswire.com/news-release/2023/05/24/2675238/0/en/ResolutionRx-Ltd-a-Subsidiary-of-RespireRx-Pharmaceuticals-Inc-Enters-into-Letter-of-Intent-with-Cantheon-Capital-for-the-Financing-of-Anticipated-Research-and-Development-Costs.html

GLOBENEWSWIRE
24 May 2023

https://www.globenewswire.com/news-release/2023/03/01/2618229/0/en/ResolutionRx-Ltd-and-RespireRx-Pharmaceuticals-Inc-Announce-ResolutionRx-s-Entry-into-a-Services-Agreement-with-iNGENu-CRO-Pty-Ltd.html

GLOBENEWSWIRE
01 Mar 2023

https://www.globenewswire.com/news-release/2023/02/01/2599491/0/en/ResolutionRx-Ltd-a-wholly-owned-subsidiary-of-RespireRx-Pharmaceuticals-Inc-Enters-into-LOI-and-Term-Sheet-with-Radium-Capital-for-the-financing-of-anticipated-Research-and-Develop.html

GLOBENEWSWIRE
01 Feb 2023

https://www.globenewswire.com/news-release/2023/01/12/2587879/0/en/RespireRx-Pharmaceuticals-Inc-Establishes-ResolutionRx-Ltd-in-Australia-to-Develop-Its-Pharmaceutical-Cannabinoid-Platform.html

GLOBENEWSWIRE
12 Jan 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty